RT @RheumatolTher: The 2nd most highly read paper of 2018 was a matched-adjusted indirect comparison of the effectiveness of secukinumab ve…
RT @RheumatolTher: The 2nd most highly read paper of 2018 was a matched-adjusted indirect comparison of the effectiveness of secukinumab ve…
The 2nd most highly read paper of 2018 was a matched-adjusted indirect comparison of the effectiveness of secukinumab versus adalimumab for #PsoriaticArthritis. See the full paper here https://t.co/5pZe0h926R and the associated video content here https://t
Take a look at the interesting and informative animated video associated with this article, describing the rationale behind using a matched-adjusted indirect comparison: https://t.co/TQJIx5JQzc #digitalcontent #psoriaticarthritis https://t.co/1iFU3ebhqW
Just published: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison https://t.co/5pZe0h926R #psoriaticarthritis #arthritis https://t.co/pE28tm4f2r